Perceptive Advisors portfolio
109 tracked investments, 13 on the map, $4.4B raised across the mapped portfolio.
- Ocular TherapeutixPost-IPO Equity
- Zentalis
- Amylyx PharmaceuticalsSeries C
- Synthego
- AbsciVenture
- Stoke TherapeuticsSeries B
- Anteris TechnologiesPost-IPO Equity
- TORL BioTherapeuticsSeries B
- Bridge to LifeDebt Financing
- M3 BiotechnologyPost-IPO Equity
- SpringWorks TherapeuticsPost-IPO Equity
- PanTheryxDebt Financing
- REGENXBIOSeries D
Also in the portfolio
- Honor
- Talkiatry
- Caris Life Sciences
- Apogee Therapeutics
- Orchestra BioMed
- SOPHiA GENETICS
- Nautilus Biotechnology
- Omada Health
- Nuvation Bio
- Kardigan
- Forge Biologics
- Zevra Therapeutics
- PROCEPT BioRobotics
- GeneDx
- Crossover Health
- Singular Genomics
- Genome Medical
- Kindbody
- Capstan Therapeutics
- Rapport Therapeutics
- RayzeBio
- Emulate
- Crinetics Pharmaceuticals
- SomaLogic
- CARGO Therapeutics
- DNAnexus
- CareDx
- InSightec
- Affinia Therapeutics
- BridgeBio
- Vyome Therapeutics
- CinCor Pharma
- Trinity Biotech
- Saama
- A-Alpha Bio
- Impulse Dynamics
- Avidity Biosciences
- Establishment Labs
- Cue
- Edgewise Therapeutics
- Marea Therapeutics
- Soleno Therapeutics
- MeiraGTx
- Outset Medical
- Beam Therapeutics
- Sionna Therapeutics
- Surf Bio
- Avita Medical
- IsoPlexis
- AavantiBio
- Pheon Therapeutics
- Orpyx
- ArcherDX
- Yarrow
- Allogene Therapeutics
- Apyx Medical
- C4 Therapeutics
- ADMA Biologics
- AVEO Oncology
- Cerebral Therapeutics